193 related articles for article (PubMed ID: 37233759)
1. Genome-wide association analysis identifies ancestry-specific genetic variation associated with acute response to metformin and glipizide in SUGAR-MGH.
Li JH; Brenner LN; Kaur V; Figueroa K; Schroeder P; Huerta-Chagoya A; ; ; Udler MS; Leong A; Mercader JM; Florez JC
Diabetologia; 2023 Jul; 66(7):1260-1272. PubMed ID: 37233759
[TBL] [Abstract][Full Text] [Related]
2. The study to understand the genetics of the acute response to metformin and glipizide in humans (SUGAR-MGH): design of a pharmacogenetic resource for type 2 diabetes.
Walford GA; Colomo N; Todd JN; Billings LK; Fernandez M; Chamarthi B; Warner AS; Davis J; Littleton KR; Hernandez AM; Fanelli RR; Lanier A; Barbato C; Ackerman RJ; Khan SQ; Bui R; Garber L; Stolerman ES; Moore AF; Huang C; Kaur V; Harden M; Taylor A; Chen L; Manning AK; Huang P; Wexler D; McCarthy RM; Lo J; Thomas MK; Grant RW; Goldfine A; Hudson MS; Florez JC
PLoS One; 2015; 10(3):e0121553. PubMed ID: 25812009
[TBL] [Abstract][Full Text] [Related]
3.
Srinivasan S; Kaur V; Chamarthi B; Littleton KR; Chen L; Manning AK; Merino J; Thomas MK; Hudson M; Goldfine A; Florez JC
Diabetes Care; 2018 Mar; 41(3):554-561. PubMed ID: 29326107
[TBL] [Abstract][Full Text] [Related]
4. The power of TOPMed imputation for the discovery of Latino-enriched rare variants associated with type 2 diabetes.
Huerta-Chagoya A; Schroeder P; Mandla R; Deutsch AJ; Zhu W; Petty L; Yi X; Cole JB; Udler MS; Dornbos P; Porneala B; DiCorpo D; Liu CT; Li JH; Szczerbiński L; Kaur V; Kim J; Lu Y; Martin A; Eizirik DL; Marchetti P; Marselli L; Chen L; Srinivasan S; Todd J; Flannick J; Gubitosi-Klug R; Levitsky L; Shah R; Kelsey M; Burke B; Dabelea DM; Divers J; Marcovina S; Stalbow L; Loos RJF; Darst BF; Kooperberg C; Raffield LM; Haiman C; Sun Q; McCormick JB; Fisher-Hoch SP; Ordoñez ML; Meigs J; Baier LJ; González-Villalpando C; González-Villalpando ME; Orozco L; García-García L; Moreno-Estrada A; ; Aguilar-Salinas CA; Tusié T; Dupuis J; Ng MCY; Manning A; Highland HM; Cnop M; Hanson R; Below J; Florez JC; Leong A; Mercader JM
Diabetologia; 2023 Jul; 66(7):1273-1288. PubMed ID: 37148359
[TBL] [Abstract][Full Text] [Related]
5. Genome-Wide Meta-analysis Identifies Genetic Variants Associated With Glycemic Response to Sulfonylureas.
Dawed AY; Yee SW; Zhou K; van Leeuwen N; Zhang Y; Siddiqui MK; Etheridge A; Innocenti F; Xu F; Li JH; Beulens JW; van der Heijden AA; Slieker RC; Chang YC; Mercader JM; Kaur V; Witte JS; Lee MTM; Kamatani Y; Momozawa Y; Kubo M; Palmer CNA; Florez JC; Hedderson MM; 't Hart LM; Giacomini KM; Pearson ER; ;
Diabetes Care; 2021 Dec; 44(12):2673-2682. PubMed ID: 34607834
[TBL] [Abstract][Full Text] [Related]
6. The presence of two reduced function variants in CYP2C9 influences the acute response to glipizide.
Chen L; Li JH; Kaur V; Muhammad A; Fernandez M; Hudson MS; Goldfine AB; Florez JC
Diabet Med; 2020 Dec; 37(12):2124-2130. PubMed ID: 31709648
[TBL] [Abstract][Full Text] [Related]
7. Multicenter, randomized, double-masked, parallel-group assessment of simultaneous glipizide/metformin as second-line pharmacologic treatment for patients with type 2 diabetes mellitus that is inadequately controlled by a sulfonylurea.
Goldstein BJ; Pans M; Rubin CJ
Clin Ther; 2003 Mar; 25(3):890-903. PubMed ID: 12852706
[TBL] [Abstract][Full Text] [Related]
8. Durability of the efficacy and safety of alogliptin compared with glipizide in type 2 diabetes mellitus: a 2-year study.
Del Prato S; Camisasca R; Wilson C; Fleck P
Diabetes Obes Metab; 2014 Dec; 16(12):1239-46. PubMed ID: 25132212
[TBL] [Abstract][Full Text] [Related]
9. Transethnic insight into the genetics of glycaemic traits: fine-mapping results from the Population Architecture using Genomics and Epidemiology (PAGE) consortium.
Bien SA; Pankow JS; Haessler J; Lu Y; Pankratz N; Rohde RR; Tamuno A; Carlson CS; Schumacher FR; Bůžková P; Daviglus ML; Lim U; Fornage M; Fernandez-Rhodes L; Avilés-Santa L; Buyske S; Gross MD; Graff M; Isasi CR; Kuller LH; Manson JE; Matise TC; Prentice RL; Wilkens LR; Yoneyama S; Loos RJF; Hindorff LA; Le Marchand L; North KE; Haiman CA; Peters U; Kooperberg C
Diabetologia; 2017 Dec; 60(12):2384-2398. PubMed ID: 28905132
[TBL] [Abstract][Full Text] [Related]
10. Heritability of variation in glycaemic response to metformin: a genome-wide complex trait analysis.
Zhou K; Donnelly L; Yang J; Li M; Deshmukh H; Van Zuydam N; Ahlqvist E; ; Spencer CC; Groop L; Morris AD; Colhoun HM; Sham PC; McCarthy MI; Palmer CN; Pearson ER
Lancet Diabetes Endocrinol; 2014 Jun; 2(6):481-7. PubMed ID: 24731673
[TBL] [Abstract][Full Text] [Related]
11. Durability of glycaemic efficacy over 2 years with dapagliflozin versus glipizide as add-on therapies in patients whose type 2 diabetes mellitus is inadequately controlled with metformin.
Nauck MA; Del Prato S; Durán-García S; Rohwedder K; Langkilde AM; Sugg J; Parikh SJ
Diabetes Obes Metab; 2014 Nov; 16(11):1111-20. PubMed ID: 24919526
[TBL] [Abstract][Full Text] [Related]
12. Multi-ethnic GWAS and fine-mapping of glycaemic traits identify novel loci in the PAGE Study.
Downie CG; Dimos SF; Bien SA; Hu Y; Darst BF; Polfus LM; Wang Y; Wojcik GL; Tao R; Raffield LM; Armstrong ND; Polikowsky HG; Below JE; Correa A; Irvin MR; Rasmussen-Torvik LJF; Carlson CS; Phillips LS; Liu S; Pankow JS; Rich SS; Rotter JI; Buyske S; Matise TC; North KE; Avery CL; Haiman CA; Loos RJF; Kooperberg C; Graff M; Highland HM
Diabetologia; 2022 Mar; 65(3):477-489. PubMed ID: 34951656
[TBL] [Abstract][Full Text] [Related]
13. Probable hypoglycemic adverse drug reaction associated with prickly pear cactus, glipizide, and metformin in a patient with type 2 diabetes mellitus.
Sobieraj DM; Freyer CW
Ann Pharmacother; 2010; 44(7-8):1334-7. PubMed ID: 20516361
[TBL] [Abstract][Full Text] [Related]
14. A variant of the glucose transporter gene SLC2A2 modifies the glycaemic response to metformin therapy in recently diagnosed type 2 diabetes.
Rathmann W; Strassburger K; Bongaerts B; Kuss O; Müssig K; Burkart V; Szendroedi J; Kotzka J; Knebel B; Al-Hasani H; Roden M;
Diabetologia; 2019 Feb; 62(2):286-291. PubMed ID: 30413829
[TBL] [Abstract][Full Text] [Related]
15. Efficacy and safety of the dipeptidyl peptidase-4 inhibitor, sitagliptin, compared with the sulfonylurea, glipizide, in patients with type 2 diabetes inadequately controlled on metformin alone: a randomized, double-blind, non-inferiority trial.
Nauck MA; Meininger G; Sheng D; Terranella L; Stein PP;
Diabetes Obes Metab; 2007 Mar; 9(2):194-205. PubMed ID: 17300595
[TBL] [Abstract][Full Text] [Related]
16. [Dapagliflozin versus glipizide as add-on therapy in patients with type 2 diabetes who have inadequate glycemic control with metformin].
Nauck M; del Prato S; Meier JJ; Durán-García S; Rohwedder K; Elze M; Parikh SJ
Dtsch Med Wochenschr; 2013 Apr; 138 Suppl 1():S6-15. PubMed ID: 23529570
[TBL] [Abstract][Full Text] [Related]
17. Repaglinide : a pharmacoeconomic review of its use in type 2 diabetes mellitus.
Plosker GL; Figgitt DP
Pharmacoeconomics; 2004; 22(6):389-411. PubMed ID: 15099124
[TBL] [Abstract][Full Text] [Related]
18. Insulin and glucose-lowering agents for treating people with diabetes and chronic kidney disease.
Lo C; Toyama T; Wang Y; Lin J; Hirakawa Y; Jun M; Cass A; Hawley CM; Pilmore H; Badve SV; Perkovic V; Zoungas S
Cochrane Database Syst Rev; 2018 Sep; 9(9):CD011798. PubMed ID: 30246878
[TBL] [Abstract][Full Text] [Related]
19. Safety and efficacy of treatment with sitagliptin or glipizide in patients with type 2 diabetes inadequately controlled on metformin: a 2-year study.
Seck T; Nauck M; Sheng D; Sunga S; Davies MJ; Stein PP; Kaufman KD; Amatruda JM;
Int J Clin Pract; 2010 Apr; 64(5):562-76. PubMed ID: 20456211
[TBL] [Abstract][Full Text] [Related]
20. Metabolic effects of chronic glipizide gastrointestinal therapeutic system on serum glucose, insulin secretion, insulin sensitivity, and hepatic insulin extraction in glucose-tolerant, first-degree relatives of African American patients with type 2 diabetes: new insights on mechanisms of action.
Osei K; Rhinesmith S; Gaillard T; Schuster D
Metabolism; 2003 May; 52(5):565-72. PubMed ID: 12759885
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
